Pale Fire Capital SE’s X4 Pharmaceuticals XFOR Stock Holding History

Pale Fire Capital SE’s Portfolio XFOR Stock Details XFOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$692K	Hold	167,590	–	–	0.06%	32
2025 Q4	$670K	Sell	167,590 -13,261	-7%	-$48.2K	0.05%	35
2025 Q3	$619K	Buy	180,851 +120,800	+201%	+$312K	0.07%	31
2025 Q2	$114K	Sell	60,051 -7,794	-11%	-$31.9K	0.01%	53
2025 Q1	$481K	Buy	67,845 +21,113	+45%	+$291K	0.06%	31
2024 Q4	$1.03M	Sell	46,732 -6,694	-13%	-$107K	0.23%	19
2024 Q3	$1.07M	Buy	53,426 +47,525	+805%	+$992K	0.17%	26
2024 Q2	$103K	Buy	5,901 +4,632	+365%	+$151K	0.01%	38
2024 Q1	$52.9K	Buy	+1,269	New	+$35.3K	0.01%	50

Other funds holding XFOR

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $141M AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Pale Fire Capital SE's XFOR Position: Q1 2026 in Review

Pale Fire Capital SE held its X4 Pharmaceuticals (XFOR) position steady in Q1 2026 at 167,590 shares worth $692K. The position accounts for 0.06% of the portfolio, ranked #32.

Pale Fire Capital SE first reported a position in XFOR in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.07M in Q3 2024. 84 funds tracked by Wall St. Rank hold XFOR as of Q1 2026.

Pale Fire Capital SE held 167,590 shares of X4 Pharmaceuticals worth $692K as of Q1 2026.
Pale Fire Capital SE left its X4 Pharmaceuticals share count unchanged in Q1 2026.
X4 Pharmaceuticals made up 0.06% of Pale Fire Capital SE's portfolio in Q1 2026, its #32 holding.
Pale Fire Capital SE first reported a position in X4 Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
Pale Fire Capital SE's X4 Pharmaceuticals position peaked at $1.07M in Q3 2024.
84 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q1 2026.

Based on Pale Fire Capital SE's 13F filing for Q1 2026, filed 14 May 2026.